stella
beta
Enzalutamide and PDS01ADC in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy — Stella
Recruiting
Back to Prostate Cancer trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
United States
National Institutes of Health Clinical Center, Bethesda, Maryland
View full record on ClinicalTrials.gov